論文・技術情報追加のお知らせ

①More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matching.

ファジー文字列マッチングによるFAERS重複削除法の開発

対象DB：FAERS

②Abuse, dependence and withdrawal associated with fentanyl and the role of its (designated) route of administration: an analysis of spontaneous reports from Europe.

フェンタニルに関連するファーマコビジランス研究

対象DB：EudraVigilance

③Safety Profiles of mRNA COVID-19 Vaccines Using World Health Organization Global Scale Database (VigiBase): A Latent Class Analysis.

mRNA COVID-19ワクチンの安全性プロファイル

対象DB：VigiBase

④Comparative Effects of 30 Antipsychotics on Risk of Catatonia: An Analysis of the WHO Pharmacovigilance Database.

緊張病リスクに対する30種類の抗精神病薬比較効果

対象DB：VigiBase

⑤Antipsychotics and risk of QT prolongation: a pharmacovigilance study.

抗精神病薬とQT延長のリスクに関するファーマコビジランス研究

対象DB：VigiBase

⑥Adverse drug reactions in pregnant women: Do they differ from those in non-pregnant women of childbearing age?

妊娠中の女性における薬物有害反応調査研究

対象DB：FPVD

⑦A study of the regional differences in propacetamol-related adverse events using VigiBase data of the World Health Organization.

プロパケタモール関連有害事象の地域差に関する研究

対象DB：VigiBase

⑧Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries.

クロザピン関連心筋炎ファーマコビジランス研究

対象DB：VigiBase